Heba A. S. El‐Nashar
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities 11
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection 7
- Psidium guajava Extracts and Applications 5
-
- Phytochemicals and Medicinal Plants 5
- Food Science top 2%
- Essential Oils and Antimicrobial Activity 17
- Toxicology top 5%
-
- Natural Antidiabetic Agents Studies 12
-
- Natural product bioactivities and synthesis 8
-
- Phytochemistry and Biological Activities 8
- Co-authors
- Omayma A. EldahshanMohamed El‐ShazlyNada M. MostafaAbdel Nasser B. SingabEman A. AbdelghffarLucian HriţcuShaza H. AlyMariam I. Gamal El‐Din
- Journals
- PLoS ONE (1 paper)Scientific Reports (4 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- EgyptSaudi ArabiaBangladesh
In The Last Decade
Heba A. S. El‐Nashar
66 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Biochemistry 241
- Pharmacology 273
- Complementary and alternative medicine 179
- Food Science 381
- Toxicology 43
Countries citing papers authored by Heba A. S. El‐Nashar
This map shows the geographic impact of Heba A. S. El‐Nashar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba A. S. El‐Nashar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba A. S. El‐Nashar more than expected).
Fields of papers citing papers by Heba A. S. El‐Nashar
This network shows the impact of papers produced by Heba A. S. El‐Nashar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba A. S. El‐Nashar. The network helps show where Heba A. S. El‐Nashar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heba A. S. El‐Nashar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 20 | |
| 10 | 2023 | 24 | |
| 11 | 2023 | 25 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 24 | |
| 14 | 2023 | 27 | |
| 15 | 2023 | 23 | |
| 16 | 2022 | 34 | |
| 17 | 2022 | 25 | |
| 18 | 2022 | 57 | |
| 19 | 2020 | 41 | |
| 20 | 2019 | 53 |
About Heba A. S. El‐Nashar
Heba A. S. El‐Nashar is a scholar working on Pharmacology, Biochemistry and Complementary and alternative medicine, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include Essential Oils and Antimicrobial Activity (17 papers), Natural Antidiabetic Agents Studies (12 papers), Phytochemicals and Antioxidant Activities (11 papers), Natural product bioactivities and synthesis (8 papers), Phytochemistry and Biological Activities (8 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Psidium guajava Extracts and Applications (5 papers) and Phytochemicals and Medicinal Plants (5 papers). The work is most often cited by research in Biochemistry (241 citations), Pharmacology (273 citations) and Complementary and alternative medicine (179 citations). Heba A. S. El‐Nashar has collaborated with scholars based in Egypt, Saudi Arabia and Bangladesh. Frequent co-authors include Omayma A. Eldahshan, Mohamed El‐Shazly, Nada M. Mostafa, Abdel Nasser B. Singab, Eman A. Abdelghffar, Lucian Hriţcu, Shaza H. Aly, Mariam I. Gamal El‐Din, Wagdy M. Eldehna and Naglaa S. Ashmawy. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.